the effect of Tiaoshen Acupuncture for cancer fatigue in breast cancer survivors based on metabolomics analysis

注册号:

Registration number:

ITMCTR1900002874

最近更新日期:

Date of Last Refreshed on:

2019-12-27

注册时间:

Date of Registration:

2019-12-27

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

基于代谢组学分析调神针法对乳腺癌幸存者癌性疲劳的干预作用

Public title:

the effect of Tiaoshen Acupuncture for cancer fatigue in breast cancer survivors based on metabolomics analysis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于代谢组学分析调神针法对乳腺癌幸存者癌性疲劳的干预作用

Scientific title:

the effect of Tiaoshen Acupuncture for cancer fatigue in breast cancer survivors based on metabolomics analysis

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR1900028543 ; ChiMCTR1900002874

申请注册联系人:

李金霞

研究负责人:

李金霞

Applicant:

LI Jinxia

Study leader:

LI Jinxia

申请注册联系人电话:

Applicant telephone:

+86 13857299145

研究负责人电话:

Study leader's telephone:

+86 13857299145

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lijinxia310@163.com

研究负责人电子邮件:

Study leader's E-mail:

lijinxia310@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

浙江省湖州市南街315号

研究负责人通讯地址:

浙江省湖州市南街315号

Applicant address:

315 South Street, Huzhou, Zhejiang, China

Study leader's address:

315 South Street, Huzhou, Zhejiang, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

浙江中医药大学附属湖州中医院

Applicant's institution:

Traditional Chinese Medical Hospital of Huzhou,Affiliated to Traditional Chinese Medical University of Zhejiang

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2019-077-A号

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

湖州市中医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Huzhou Traditional Chinese Medicine Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2019/12/18 0:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

浙江中医药大学附属湖州中医院

Primary sponsor:

Traditional Chinese Medical Hospital of Huzhou,Affiliated to Traditional Chinese Medical University of Zhejiang

研究实施负责(组长)单位地址:

浙江省湖州市南街315号

Primary sponsor's address:

315 South Street, Huzhou, Zhejiang, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江中医药大学附属湖州中医院

具体地址:

浙江省湖州市南街315号

Institution
hospital:

浙江中医药大学附属湖州中医院

Address:

315 South Street, Huzhou

经费或物资来源:

浙江省基础公益研究项目

Source(s) of funding:

Zhejiang basic public welfare research project

研究疾病:

癌性疲劳

研究疾病代码:

Target disease:

Cancer Related Fatigue

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

(1)阐明调神针法是否通过调节代谢组学相关代谢标志物水平来缓解乳腺癌幸存者癌性疲劳。 (2)验证调神针法对乳腺癌幸存者癌性疲劳的有效性。

Objectives of Study:

(1) to clarify whether the toning needle method can alleviate the cancer fatigue of breast cancer survivors by regulating the level of metabolomics related metabolic markers; (2) verify the effectiveness of toning needle therapy for cancer fatigue in breast cancer survivors.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.符合乳腺癌幸存者及癌性疲劳的诊断标准; 2. 乳腺癌手术后3-6个月内,且未在化疗期间; 3. 年龄18~75岁,性别不限; 4. Karnofsky功能状态评分表(KPS)评分大于等于60分者; 5. 同意参加本研究,理解并签署知情同意书。

Inclusion criteria

1. Meet the diagnostic criteria for breast cancer survivors and cancer fatigue; 2. Within 3-6 months after surgery for breast cancer, and not during chemotherapy; 3. Aged 18-75 years; 4. Karnofsky functional status rating scale (KPS) score is greater than or equal to 60; 5. Agree to participate in this study, understand and sign the informed consent.

排除标准:

1. 乳腺癌Ⅳ级; 2.且24小时内服用任何催眠镇静药物或精神活性物质; 3.合并其他癌症或较为严重的心、肝、肾等慢性疾病; 4. 患有精神疾患,或有严重的认知障碍,不能参与合作的患者; 5. 慢性疲劳综合症等其他生理或病理性疲劳; 6. 在过去6个月内接受过针刺的患者; 7. 妊娠或哺乳期妇女。

Exclusion criteria:

1. Breast cancer IV level; 2. And take any hypnotic sedatives or psychoactive substances within 24 hours; 3. Combined with other cancers or more serious heart, liver, kidney and other chronic diseases; 4. Patients with mental disorders or severe cognitive impairment who cannot participate in cooperation; 5. Other physiological or pathological fatigue such as chronic fatigue syndrome; 6. Patients who had received acupuncture in the past 6 months; 7. Pregnant or nursing women.

研究实施时间:

Study execute time:

From 2020-01-01

To      2022-12-31

征募观察对象时间:

Recruiting time:

From 2020-01-01

To      2021-12-31

干预措施:

Interventions:

组别:

治疗组

样本量:

57

Group:

Experimental group

Sample size:

干预措施:

采用中西医基础治疗+调神针法

干预措施代码:

Intervention:

Adopt traditional Chinese and western medicine basic treatment + Tiaoshen Acupuncture

Intervention code:

组别:

对照组

样本量:

57

Group:

Control group

Sample size:

干预措施:

采用中西医基础治疗

干预措施代码:

Intervention:

Basic treatment with traditional Chinese and western medicine

Intervention code:

样本总量 Total sample size : 114

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江中医药大学附属湖州中医院

单位级别:

三级甲等

Institution/hospital:

Traditional Chinese Medical Hospital of Huzhou,Affiliated to Traditional Chinese Medical University of Zhejiang

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

疲劳症状评价(中文版多维疲劳量表)

指标类型:

次要指标

Outcome:

MFI-20

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量评价

指标类型:

次要指标

Outcome:

Karnofsky scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

睡眠质量评价(匹兹堡睡眠质量指数)

指标类型:

次要指标

Outcome:

Pittsburgh Sleep Quality Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

中医气虚相关症候积分

指标类型:

次要指标

Outcome:

Qi-deficiency related syndromes of TCM

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

代谢组学相关血清代谢标志物含量

指标类型:

主要指标

Outcome:

Metabolomics - related serum metabolic markers

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

抑郁程度评价(汉密尔顿抑郁量表)

指标类型:

次要指标

Outcome:

Hamilton Depression Scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 18
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用随机数字表产生随机分配序列。临床受试者随机号及分组信息由项目研究组专人管理,随机编号及分组信息在临床治疗前装在连续编号的信封内,受试者按纳入研究观察的时间先后顺序获得信封,并同时获得相应的随机编号和分组信息。

Randomization Procedure (please state who generates the random number sequence and by what method):

A random number table is used to generate a random distribution sequence.The random Numbers and grouping information of clinical subjects were managed by special personnel of the project research group, and the random Numbers and grouping information were placed in consecutively numbered envelopes before clinical treat

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

杂志期刊

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

journals and periodicals

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据采集和保管由数据管理专职人员负责,电子版用excel录入管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and storage by the full-time data management personnel responsible for electronic version with excel input management

数据管理委员会:

Data Managemen Committee:

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above